28472082|t|Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials
28472082|a|Although cognitive behavioral therapy (CBT) is considered a promising adjuvant to pharmacotherapy for treating bipolar disorder (BD), its efficacy is unproven. The present review and meta-analysis evaluated the treatment outcomes of patients with BD treated with CBT plus medication and compared these data with the outcomes of those who received standard care alone. Electronic searches from inception to July 31, 2016, were performed using PubMed, Medline OVID, Cochrane Library, EMBASE, CINAHL plus, and PsycINFO. In the extensive electronic literature search, keywords such as " bipolar disorder ," " manic-depressive psychosis ," " bipolar affective disorder ," " bipolar depression ," " cognitive therapy ," " cognitive-behavioral therapy ," and " psychotherapy " were transformed into MeSH terms, and only randomized controlled trials (RCTs) were included. The pooled odds ratios (ORs) of relapse rates and Hedges's g, along with 95% confidence intervals (CIs), for the mean differences in the levels of depression, mania, and psychosocial functioning were calculated. Further subgroup analyses were conducted according to the characteristics of the CBT approaches, patients, and therapists, if the data were available. A total of 19 RCTs comprising 1384 patients with type I or II BD were enrolled in our systematic review and meta-analysis. The main analysis revealed that CBT could lower the relapse rate (pooled OR = 0.506; 95% CI = 0.278 -0.921) and improve depressive symptoms (g = -0.494; 95% CI = -0.963 to -0.026), mania severity (g = -0.581; 95% CI = -1.127 to -0.035), and psychosocial functioning (g = 0.457; 95% CI = 0.106-0.809). CBT is effective in decreasing the relapse rate and improving depressive symptoms, mania severity, and psychosocial functioning, with a mild-to-moderate effect size. Subgroup analyses indicated that improvements in depression or mania are more potent with a CBT treatment duration of â‰¥90 min per session, and the relapse rate is much lower among patients with type I BD.
28472082	0	8	Efficacy	T080	C0087113
28472082	12	40	cognitive-behavioral therapy	T061	C0009244
28472082	44	52	patients	T101	C0030705
28472082	58	74	bipolar disorder	T048	C0005586
28472082	78	91	meta-analysis	T062	C0920317
28472082	95	123	randomized controlled trials	T062	C0206035
28472082	133	161	cognitive behavioral therapy	T061	C0009244
28472082	163	166	CBT	T061	C0009244
28472082	194	202	adjuvant	T169	C1522673
28472082	206	221	pharmacotherapy	T061	C0013216
28472082	226	234	treating	T169	C1522326
28472082	235	251	bipolar disorder	T048	C0005586
28472082	253	255	BD	T048	C0005586
28472082	262	270	efficacy	T080	C0087113
28472082	296	302	review	T170	C0282443
28472082	307	320	meta-analysis	T062	C0920317
28472082	321	330	evaluated	T058	C0220825
28472082	335	353	treatment outcomes	T080	C0085415
28472082	357	365	patients	T101	C0030705
28472082	371	373	BD	T048	C0005586
28472082	374	386	treated with	T061	C0332293
28472082	387	390	CBT	T061	C0009244
28472082	396	406	medication	T058	C1254363
28472082	411	419	compared	T052	C1707455
28472082	440	448	outcomes	T080	C0085415
28472082	462	470	received	T080	C1514756
28472082	471	484	standard care	T061	C2936643
28472082	492	502	Electronic	T078	C0013850
28472082	503	511	searches	T052	C1706202
28472082	550	559	performed	T169	C0884358
28472082	566	572	PubMed	T170	C1138432
28472082	574	586	Medline OVID	T170	C0025141
28472082	588	604	Cochrane Library	T170	C0282574
28472082	606	612	EMBASE	T170	C0282574
28472082	614	625	CINAHL plus	T170	C0282574
28472082	631	639	PsycINFO	T170	C1140129
28472082	658	668	electronic	T078	C0013850
28472082	669	679	literature	T170	C0023866
28472082	680	686	search	T052	C1706202
28472082	688	696	keywords	T170	C1708608
28472082	707	723	bipolar disorder	T048	C0005586
28472082	729	755	manic-depressive psychosis	T048	C0005586
28472082	761	787	bipolar affective disorder	T048	C0005586
28472082	793	811	bipolar depression	T048	C0005587
28472082	817	834	cognitive therapy	T061	C0009244
28472082	840	868	cognitive-behavioral therapy	T061	C0009244
28472082	878	891	psychotherapy	T061	C0033968
28472082	916	920	MeSH	T170	C1135584
28472082	937	965	randomized controlled trials	T062	C0206035
28472082	967	971	RCTs	T062	C0206035
28472082	992	998	pooled	T169	C2349200
28472082	999	1010	odds ratios	T081	C0028873
28472082	1012	1015	ORs	T081	C0028873
28472082	1020	1027	relapse	T067	C0035020
28472082	1028	1033	rates	T081	C1521828
28472082	1038	1048	Hedges's g	T081	C0392762
28472082	1065	1085	confidence intervals	T081	C0009667
28472082	1087	1090	CIs	T081	C0009667
28472082	1101	1105	mean	T081	C0444504
28472082	1106	1117	differences	T081	C1705241
28472082	1125	1145	levels of depression	T033	C1319226
28472082	1147	1152	mania	T048	C0338831
28472082	1158	1182	psychosocial functioning	T201	C0518884
28472082	1188	1198	calculated	T052	C1441506
28472082	1208	1216	subgroup	T185	C1515021
28472082	1217	1225	analyses	T062	C0936012
28472082	1258	1273	characteristics	T080	C1521970
28472082	1281	1284	CBT	T061	C0009244
28472082	1285	1295	approaches	T082	C0449445
28472082	1297	1305	patients	T101	C0030705
28472082	1311	1321	therapists	T097	C0871525
28472082	1330	1334	data	T078	C1511726
28472082	1340	1349	available	T169	C0470187
28472082	1353	1358	total	T080	C0439810
28472082	1365	1369	RCTs	T062	C0206035
28472082	1386	1394	patients	T101	C0030705
28472082	1400	1406	type I	T048	C0853193
28472082	1410	1415	II BD	T048	C0236788
28472082	1437	1447	systematic	T169	C0220922
28472082	1448	1454	review	T170	C0282443
28472082	1459	1472	meta-analysis	T062	C0920317
28472082	1483	1491	analysis	T062	C0936012
28472082	1506	1509	CBT	T061	C0009244
28472082	1516	1521	lower	T052	C2003888
28472082	1526	1533	relapse	T067	C0035020
28472082	1534	1538	rate	T081	C1521828
28472082	1540	1546	pooled	T169	C2349200
28472082	1547	1549	OR	T081	C0028873
28472082	1563	1565	CI	T081	C0009667
28472082	1586	1593	improve	T033	C0184511
28472082	1594	1613	depressive symptoms	T184	C0086132
28472082	1615	1616	g	T081	C0392762
28472082	1631	1633	CI	T081	C0009667
28472082	1655	1660	mania	T048	C0338831
28472082	1661	1669	severity	T080	C0392364
28472082	1671	1672	g	T081	C0392762
28472082	1687	1689	CI	T081	C0009667
28472082	1715	1739	psychosocial functioning	T201	C0518884
28472082	1741	1742	g	T081	C0392762
28472082	1756	1758	CI	T081	C0009667
28472082	1775	1778	CBT	T061	C0009244
28472082	1782	1791	effective	T080	C1704419
28472082	1795	1805	decreasing	T033	C0442797
28472082	1810	1817	relapse	T067	C0035020
28472082	1818	1822	rate	T081	C1521828
28472082	1827	1836	improving	T080	C1272745
28472082	1837	1856	depressive symptoms	T184	C0086132
28472082	1858	1863	mania	T048	C0338831
28472082	1864	1872	severity	T080	C0392364
28472082	1878	1902	psychosocial functioning	T201	C0518884
28472082	1911	1927	mild-to-moderate	T080	C1299392
28472082	1928	1939	effect size	T081	C0237589
28472082	1941	1949	Subgroup	T185	C1515021
28472082	1950	1958	analyses	T062	C0936012
28472082	1974	1986	improvements	T077	C2986411
28472082	1990	2000	depression	T048	C0011570
28472082	2004	2009	mania	T048	C0338831
28472082	2033	2036	CBT	T061	C0009244
28472082	2037	2055	treatment duration	T079	C0444921
28472082	2071	2078	session	T051	C1883016
28472082	2088	2095	relapse	T067	C0035020
28472082	2096	2100	rate	T081	C1521828
28472082	2121	2129	patients	T101	C0030705
28472082	2135	2144	type I BD	T048	C0853193